See more : City Chic Collective Limited (CCCHF) Income Statement Analysis – Financial Results
Complete financial analysis of Kanda Holdings Co.,Ltd. (9059.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kanda Holdings Co.,Ltd., a leading company in the Trucking industry within the Industrials sector.
- Nagarro SE (NA9.F) Income Statement Analysis – Financial Results
- Air T, Inc. (AIRTW) Income Statement Analysis – Financial Results
- Yuanta Securities Korea Co., Ltd. (003470.KS) Income Statement Analysis – Financial Results
- Chatham Corporation (CHTM) Income Statement Analysis – Financial Results
- WestRock Company (1WR.DE) Income Statement Analysis – Financial Results
Kanda Holdings Co.,Ltd. (9059.T)
About Kanda Holdings Co.,Ltd.
Kanda Holdings Co.,Ltd., through its subsidiaries, provides integrated logistics services in Japan and internationally. The company engages in the general freight vehicle transportation, special assortment freight forwarding, freight light and specified vehicle transportation, freight transportation, and luggage packing storage businesses. It also provides car maintenance, security, warehousing, information provision service and consulting, finance/leasing, custom clearance, and port/marine transportation services. In addition, the company is involved in the leasing, brokerage, consulting, management, and sale of real estate properties; non-life and life insurance agency businesses; industrial waste collection, transportation, and treatment activities; vehicle operation management and inspection activities, as well as maintenance contract works; software and its related equipment development contracts; and systems consulting, sales, leasing, rental, and brokerage activities. Further, the company manages dispensing pharmacies, restaurants, and parking lots; generates and sells electricity; manufactures and sells equipment, sanitary ware, etc.; and operates a car diving agency. Additionally, it engages in the civil engineering and construction planning and designing, enforcement, supervision and beauty, and cleaning of structure activities; and provides automobiles, electronic computing equipment, communication equipment, clothing, daily necessities, groceries, pharmaceuticals/quasi-drugs, cosmetics, pharmaceutical equipment, medical consumables, industry chemicals, pesticides, fuel, and air conditioning equipment, as well as imports and exports kitchen products. The company was founded in 1943 and is headquartered in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 51.12B | 51.62B | 47.65B | 44.04B | 43.74B | 43.58B | 40.93B | 39.17B | 36.88B | 34.49B | 32.61B | 28.10B | 25.48B | 23.20B | 24.64B | 25.02B | 23.99B |
Cost of Revenue | 45.29B | 46.53B | 42.41B | 39.56B | 39.88B | 39.79B | 37.05B | 35.71B | 33.62B | 31.50B | 30.00B | 25.42B | 22.65B | 21.03B | 21.82B | 22.40B | 21.30B |
Gross Profit | 5.84B | 5.09B | 5.24B | 4.47B | 3.86B | 3.80B | 3.88B | 3.46B | 3.26B | 2.99B | 2.62B | 2.69B | 2.83B | 2.17B | 2.82B | 2.62B | 2.69B |
Gross Profit Ratio | 11.42% | 9.85% | 11.00% | 10.15% | 8.82% | 8.71% | 9.47% | 8.83% | 8.85% | 8.67% | 8.02% | 9.56% | 11.12% | 9.37% | 11.45% | 10.47% | 11.23% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 424.00M | 405.00M | 355.00M | 310.00M | 285.00M | 333.00M | 332.00M | 377.00M | 383.34M | 402.40M | 370.50M | 363.59M | 359.55M | 356.38M | 316.35M | 302.09M | 302.31M |
Selling & Marketing | 1.78B | 1.74B | 1.65B | 1.63B | 1.72B | 1.76B | 1.53B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 2.20B | 2.14B | 2.00B | 1.94B | 2.01B | 2.09B | 1.86B | 377.00M | 383.34M | 402.40M | 370.50M | 363.59M | 359.55M | 356.38M | 316.35M | 302.09M | 302.31M |
Other Expenses | 207.00M | 37.00M | 16.00M | 54.00M | 82.00M | 21.00M | 55.44M | 93.11M | 95.10M | 86.24M | 72.48M | 73.10M | 54.82M | 79.85M | 60.76M | 66.40M | 93.29M |
Operating Expenses | 2.41B | 2.35B | 2.20B | 2.10B | 2.11B | 2.22B | 2.04B | 1.19B | 1.20B | 1.22B | 1.19B | 1.07B | 1.03B | 913.91M | 883.45M | 959.38M | 936.99M |
Cost & Expenses | 47.69B | 48.89B | 44.61B | 41.67B | 41.99B | 42.01B | 39.09B | 36.90B | 34.82B | 32.72B | 31.19B | 26.48B | 23.68B | 21.94B | 22.70B | 23.36B | 22.24B |
Interest Income | 0.00 | 8.00M | 4.00M | 2.00M | 45.00M | 3.00M | 3.56M | 1.62M | 2.09M | 1.82M | 2.30M | 3.51M | 3.36M | 5.72M | 5.74M | 6.98M | 7.82M |
Interest Expense | 55.00M | 50.00M | 58.00M | 65.00M | 81.00M | 88.00M | 83.38M | 90.31M | 130.52M | 145.67M | 136.07M | 126.11M | 116.32M | 127.41M | 143.39M | 170.19M | 173.33M |
Depreciation & Amortization | 1.73B | 1.69B | 1.71B | 1.61B | 1.59B | 1.58B | 1.48B | 1.54B | 1.40B | 1.42B | 1.34B | 1.10B | 1.19B | 1.11B | 1.07B | 1.34B | 1.20B |
EBITDA | 5.28B | 4.42B | 4.74B | 3.97B | 3.33B | 3.22B | 3.24B | 3.29B | 3.96B | 2.74B | 2.34B | 2.34B | 2.63B | 1.87B | 2.52B | 2.42B | 3.06B |
EBITDA Ratio | 10.33% | 8.79% | 10.15% | 9.32% | 7.85% | 7.34% | 8.25% | 9.97% | 9.67% | 9.57% | 8.76% | 9.97% | 12.01% | 10.56% | 12.47% | 12.28% | 12.77% |
Operating Income | 3.43B | 2.73B | 3.03B | 2.36B | 1.74B | 1.57B | 1.83B | 1.62B | 1.51B | 1.22B | 928.36M | 1.15B | 1.38B | 842.95M | 1.49B | 1.19B | 1.28B |
Operating Income Ratio | 6.71% | 5.29% | 6.36% | 5.37% | 3.99% | 3.59% | 4.48% | 4.14% | 4.09% | 3.55% | 2.85% | 4.10% | 5.42% | 3.63% | 6.06% | 4.77% | 5.35% |
Total Other Income/Expenses | 67.00M | 27.00M | -129.00M | -167.00M | -67.00M | -135.00M | -23.00M | 34.74M | 917.16M | -47.06M | -61.63M | -44.15M | -60.66M | -209.56M | -184.58M | -282.85M | -430.26M |
Income Before Tax | 3.50B | 2.76B | 2.90B | 2.20B | 1.74B | 1.43B | 1.81B | 1.66B | 2.43B | 1.18B | 866.37M | 1.11B | 1.32B | 633.39M | 1.31B | 909.82M | 853.59M |
Income Before Tax Ratio | 6.84% | 5.34% | 6.08% | 4.99% | 3.98% | 3.29% | 4.42% | 4.23% | 6.58% | 3.41% | 2.66% | 3.94% | 5.18% | 2.73% | 5.32% | 3.64% | 3.56% |
Income Tax Expense | 1.23B | 981.00M | 950.00M | 696.00M | 676.00M | 643.00M | 741.31M | 678.43M | 859.45M | 431.74M | 396.80M | 530.07M | 646.58M | 291.87M | 491.29M | 486.68M | 379.63M |
Net Income | 2.27B | 1.77B | 1.95B | 1.50B | 1.04B | 790.00M | 1.07B | 975.47M | 1.56B | 711.50M | 456.14M | 561.76M | 661.70M | 336.44M | 809.95M | 416.95M | 465.54M |
Net Income Ratio | 4.45% | 3.44% | 4.09% | 3.41% | 2.38% | 1.81% | 2.61% | 2.49% | 4.24% | 2.06% | 1.40% | 2.00% | 2.60% | 1.45% | 3.29% | 1.67% | 1.94% |
EPS | 105.88 | 82.41 | 90.50 | 69.73 | 49.38 | 36.70 | 49.55 | 45.32 | 72.63 | 33.06 | 21.19 | 26.10 | 30.74 | 15.63 | 37.45 | 18.76 | 20.63 |
EPS Diluted | 105.88 | 82.41 | 90.50 | 69.73 | 49.38 | 36.70 | 49.55 | 45.32 | 72.63 | 33.06 | 21.19 | 26.10 | 30.74 | 15.63 | 37.45 | 18.76 | 20.63 |
Weighted Avg Shares Out | 21.47M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.63M | 22.22M | 22.56M |
Weighted Avg Shares Out (Dil) | 21.47M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.53M | 21.63M | 22.22M | 22.56M |
MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program
ABIONYX Announces Positive Clinical Findings for CER-001 in Treating COVID-19, Published in Biomedecines, Demonstrating That CER-001 Limits Inflammation Effects
ABIONYX Pharma annonce des résultats cliniques positifs pour CER-001 dans le traitement de la COVID-19, publiés dans la revue Biomedecines, démontrant que CER-001 limite les effets de l’inflammation
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
Launching Labs Marketing Awarded Branding Agency of the Year, Colorado
Radial Plans to Fill More Than 700 Seasonal Customer Care Jobs in Melbourne, Florida, to Support ecommerce Holiday Demands
Desert Financial Donates $500K to Valley Food Banks and United Way Amidst COVID-19 Fallout
Flatiron Health Announces Research to be Presented at American Society of Clinical Oncology 2019 Annual Meeting
InfoSlips Chooses Pryon to Bring AI to Interactive Documents
Source: https://incomestatements.info
Category: Stock Reports